ACTIVE SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS
Clinical trials for ACTIVE SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new ACTIVE SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS trials appear
Sign up with your email to follow new studies for ACTIVE SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Two-Year watch: how safe is this MS injection?
Disease control CompletedThis study monitored patients with relapsing or progressive multiple sclerosis (MS) who were taking Kesimpta injections for two years. The main goal was to track side effects and see how well the drug worked at preventing relapses and slowing disability. Researchers followed 367 …
Matched conditions: ACTIVE SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Real-World tracking: can this MS drug slow disability progression?
Disease control CompletedThis study observed 134 adults in Italy with active secondary progressive multiple sclerosis (MS) who were newly starting the drug Mayzent (siponimod) as part of their regular care. Over three years, researchers tracked whether the drug helped slow the worsening of physical and m…
Matched conditions: ACTIVE SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC